Saito Yutaro, Ohta Nobuo, Konosu-Fukaya Sachiko, Shoji Fumi, Suzuki Takahiro, Noguchi Naoya, Kakuta Risako, Ikeda Ryoukichi, Yamazaki Muneharu, Kusano Yusuke, Ishida Yusuke, Satake Masafumi, Ise Kazue, Kagaya Yuriko, Tamura Ryo, Murakami Kazuhiro, Nakamura Yasuhiro
Division of Otolaryngology, Tohoku Medical and Pharmaceutical University, Sendai 981-0905, Japan.
Division of Pathology, Tohoku Medical and Pharmaceutical University, Sendai 981-0905, Japan.
Yonago Acta Med. 2019 Jun 20;62(2):236-239. doi: 10.33160/yam.2019.06.009. eCollection 2019 Jun.
A 71-year-old Japanese male patient presented with a rare case of Glomangiopericytoma (GPC) of the left nasal with obstruction. Complete resection with endoscopic surgery was performed. Immunohistochemical staining for smooth muscle actin, β catenin, cyclin D1, vimentin, and factor 13 were helpful in establishing a definitive diagnosis. Extranasal treatment has been traditionally performed for successful management. However, recent advances in endoscopic treatment have enabled complete endoscopic resection of GPC, minimizing morbidity and facilitating subsequent surveillance for recurrence. Endoscopic management should be considered in suitable cases.
一名71岁的日本男性患者，因左鼻腔罕见的血管外皮细胞瘤（GPC）伴鼻塞前来就诊。通过内镜手术进行了完整切除。平滑肌肌动蛋白、β连环蛋白、细胞周期蛋白D1、波形蛋白和因子13的免疫组织化学染色有助于明确诊断。传统上，鼻外治疗是成功治疗的方法。然而，内镜治疗的最新进展已使GPC能够通过内镜完全切除，将发病率降至最低，并便于后续复发监测。对于合适的病例应考虑内镜治疗。
